Mydecine Innovations Group Inc. (CSE: MYCO)

CSE: MYCO Statistics

Total Valuation

Mydecine Innovations Group has a market cap or net worth of CAD 355,030. The enterprise value is 7.24 million.

Market Cap	355,030
Enterprise Value	7.24M

Important Dates

The next estimated earnings date is Monday, March 31, 2025.

Earnings Date	Mar 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+163.36%
Shares Change (QoQ)	+0.92%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	60.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.58
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.01

Current Ratio	0.01
Quick Ratio	0.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.15

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-188.53%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.00% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-80.00%
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	35.05
Average Volume (20 Days)	94,692

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.07

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-6.99M
Pretax Income	-12.46M
Net Income	-12.46M
EBITDA	-6.98M
EBIT	-6.99M
Earnings Per Share (EPS)	-0.22

Balance Sheet

The company has 60,173 in cash and 6.53 million in debt, giving a net cash position of -6.47 million.

Cash & Cash Equivalents	60,173
Total Debt	6.53M
Net Cash	-6.47M
Net Cash Per Share	n/a
Equity (Book Value)	-17.45M
Book Value Per Share	-0.28
Working Capital	-17.45M

Cash Flow

Operating Cash Flow	-350,166
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mydecine Innovations Group does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-163.36%
Shareholder Yield	-163.36%
Earnings Yield	-4,403.34%
FCF Yield	n/a

Stock Splits

The last stock split was on April 21, 2022. It was a reverse split with a ratio of 0.02.

Last Split Date	Apr 21, 2022
Split Type	Reverse
Split Ratio	0.02

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a